Advances in Influenza Treatment: Optimizing Outcomes in High-Risk Influenza Patients with Chronic Cardiometabolic Conditions

The Emerging Role of Novel GLP-1 RAs in the Management of T2DM: Assessing the Rationale and Evidence

The Changing Landscape of NASH: Navigating Current and Emerging Approaches in Diagnosis and Treatment

Virtual Symposium: Addressing the Unmet Need of Diabetic Kidney Disease Progression: Beyond SGLT-2 Inhibitors and GLP-1 Ras